Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer

Urologia Internationalis, 04/30/2012

The optimal approach in the management of advanced urothelial cancer continues to evolve. Further progress relies on the expansion of research into tumor biology and an understanding of the underlying molecular ‘fingerprints’ that can be used to enhance diagnostic and therapeutic strategies. Cisplatin–based therapy has had the best track record thus far.

Print Article Summary Cat 2 CME Report